Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid.

Literature DB >> 4853069

Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid.

Abstract

The major phospholipids of hepatitis B antigen, subtype adw, were characterized as phosphatidylcholine, sphingomyelin, and lysophosphatidylcholine. In addition, two carbohydrate-containing lipids were observed, one of which was characterized as a non-sialic acid-containing, water-soluble glycosphingolipid. Upon hydrolysis the glycosphingolipid yielded both hydroxy and non-hydroxy fatty acid as well as a long-chain base which was putatively identified as dihydrosphingosine.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1974 PMID： 4853069 PMCID： PMC355551

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

22 in total

1. The heterogeneity of Australia antigen.

Authors: G L Le Bouvier
Journal: J Infect Dis Date: 1971-06 Impact factor: 5.226

2. Stability of the lipid and protein of hepatitis-associated (Australia) antigen.

Authors: C Y Kim; D M Bissell
Journal: J Infect Dis Date: 1971-05 Impact factor: 5.226

3. The occurrence of diphosphoinositide and triphosphoinositide in Saccharomyces cerevisiae.

Authors: R L Lester; M R Steiner
Journal: J Biol Chem Date: 1968-09-25 Impact factor: 5.157

4. Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines.

Authors: S I Hakomori; W T Murakami
Journal: Proc Natl Acad Sci U S A Date: 1968-01 Impact factor: 11.205

5. Biophysical properties of Australia antigen.

Authors: J L Gerin; R H Purcell; M D Hoggan; P V Holland; R M Chanock
Journal: J Virol Date: 1969-11 Impact factor: 5.103

6. Some antigenic and physical properties of virus-like particles in sera of hepatitis patients.

Authors: L F Barker; K O Smith; W D Gehle; N R Shulman
Journal: J Immunol Date: 1969-06 Impact factor: 5.422

7. Immunochemical reactions of lipids.

Authors: M M Rapport; L Graf
Journal: Prog Allergy Date: 1969

8. Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

Authors: G R Dreesman; F B Hollinger; J R Suriano; R S Fujioka; J P Brunschwig; J L Melnick
Journal: J Virol Date: 1972-09 Impact factor: 5.103

9. Isolation and partial characterization of a major inositol-containing lipid in baker's yeast, mannosyl-diinositol, diphosphoryl-ceramide.

Authors: S Steiner; S Smith; C J Waechter; R L Lester
Journal: Proc Natl Acad Sci U S A Date: 1969-11 Impact factor: 11.205

Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid.

1. The heterogeneity of Australia antigen.

2. Stability of the lipid and protein of hepatitis-associated (Australia) antigen.

3. The occurrence of diphosphoinositide and triphosphoinositide in Saccharomyces cerevisiae.

4. Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines.

5. Biophysical properties of Australia antigen.

6. Some antigenic and physical properties of virus-like particles in sera of hepatitis patients.

7. Immunochemical reactions of lipids.

8. Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

9. Isolation and partial characterization of a major inositol-containing lipid in baker's yeast, mannosyl-diinositol, diphosphoryl-ceramide.

10. Australia antigen (a hepatitis-associated antigen): purification and physical properties.

1. Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

2. Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

Review 3. The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

4. Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

5. Multiple chemical forms of hepatitis B surface antigen produced in yeast.

Review 6. Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets.